Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation

心源性休克 四分位间距 医学 危险系数 二尖瓣反流 心脏病学 内科学 心力衰竭 休克(循环) 置信区间 死亡率 外科 心肌梗塞
作者
Richard G. Jung,Trevor Simard,Christopher P. Kovach,Kelsey M. Flint,Creighton W. Don,Pietro Di Santo,Marianna Adamo,Luca Branca,Francesca Valentini,Tomas Benito‐González,Felipe Fernández‐Vazquez,Rodrigo Estévez‐Loureiro,Alessandra Berardini,Nicolina Conti,Claudio Rapezzi,Elena Biagini,Simon Parlow,Risa Shorr,Amos Levi,Ana Manovel,Rosa Cardenal-Piris,Jose Fernandez,Mony Shuvy,Dan Haberman,Alessandra Sala,Mohamad Alkhouli,Claudia Marini,Marta Bargagna,Davide Schiavi,Paolo Denti,Sinisa Markovic,Nicola Buzzatti,Vincent Chan,Mark Hynes,Thierry Mesana,Marino Labinaz,Federico Pappalardo,Maurizio Taramasso,Benjamin Hibbert
出处
期刊:Jacc-cardiovascular Interventions [Elsevier]
卷期号:14 (1): 1-11 被引量:65
标识
DOI:10.1016/j.jcin.2020.08.037
摘要

The aim of this study was to evaluate the outcome of transcatheter mitral valve repair (TMVr) in patients with cardiogenic shock and significant mitral regurgitation (MR). Patients in cardiogenic shock with severe MR have a poor prognosis in the setting of conventional medical therapy. Because of its favorable safety profile, TMVr is being increasingly used as an acute therapy in this population, though its efficacy remains unknown. A multicenter, collaborative, patient-level analysis was conducted. Patients with cardiogenic shock and moderate to severe (3+) or severe (4+) MR who were not surgical candidates were treated with TMVr. The primary outcome was in-hospital mortality. Secondary outcomes included 90-day mortality, heart failure (HF) hospitalization, and the combined event rate of 90-day mortality and HF hospitalization following dichotomization by TMVr device success. Between January 2011 and February 2019, 141 patients across 14 institutions met the inclusion criteria. In-hospital mortality occurred in 22 patients (15.6%), at 90 days in 38 patients (29.5%), and at one year in 55 patients (42.6%). Median length of hospital stay following TMVr was 10 days (interquartile range: 6 to 20 days). HF hospitalization occurred in 26 patients (18.4%) at a median of 73 days (interquartile range: 26 to 546 days). When stratified by TMVr procedural results, successful TMVr reduced rates of in-hospital mortality (hazard ratio [HR]: 0.36; 95% confidence interval [CI]: 0.13 to 0.98; p = 0.04), 90-day mortality (HR: 0.36; 95% CI: 0.16 to 0.78; p = 0.01), and the composite of 90-day mortality and HF hospitalization (HR: 0.41; 95% CI: 0.19 to 0.90; p = 0.03). TMVr may improve short- and intermediate-term mortality in high-risk patients with cardiogenic shock and moderate to severe MR. Randomized studies are needed to definitively establish MR as a therapeutic target in patients with cardiogenic shock.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
huangsongsong完成签到,获得积分20
1秒前
科研通AI2S应助害怕的擎宇采纳,获得10
1秒前
orixero应助林子采纳,获得10
1秒前
2秒前
binglangcha发布了新的文献求助10
2秒前
这是一个昵称完成签到,获得积分10
3秒前
3秒前
星辰大海应助缓缓矛盾体采纳,获得10
3秒前
4秒前
汉堡包应助李振华采纳,获得10
4秒前
小赞发布了新的文献求助10
5秒前
6秒前
科研通AI2S应助科研通管家采纳,获得10
7秒前
无花果应助科研通管家采纳,获得10
7秒前
搜集达人应助科研通管家采纳,获得10
7秒前
香蕉觅云应助科研通管家采纳,获得10
7秒前
烟花应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
8秒前
Hello应助科研通管家采纳,获得10
8秒前
xiaoGuo应助科研通管家采纳,获得10
8秒前
彭于晏应助科研通管家采纳,获得10
8秒前
ding应助科研通管家采纳,获得10
8秒前
JamesPei应助科研通管家采纳,获得10
8秒前
小马甲应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
Mr发布了新的文献求助10
8秒前
lysixsixsix完成签到,获得积分10
9秒前
婳祎完成签到 ,获得积分10
9秒前
尊敬的yy完成签到,获得积分10
9秒前
tuotuo发布了新的文献求助10
10秒前
hh完成签到,获得积分10
10秒前
11秒前
醉熏的荣轩完成签到,获得积分20
12秒前
Anqi完成签到 ,获得积分10
12秒前
13秒前
cd发布了新的文献求助10
13秒前
14秒前
14秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141127
求助须知:如何正确求助?哪些是违规求助? 2792031
关于积分的说明 7801479
捐赠科研通 2448267
什么是DOI,文献DOI怎么找? 1302482
科研通“疑难数据库(出版商)”最低求助积分说明 626591
版权声明 601226